IVF HARTMANN HOLDING AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 142 CHF | -0.70% |
|
+2.90% | +26.79% |
| Feb. 23 | IVF Hartmann Holding AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | IVF Hartmann Logs Improved H1 Profit; Revenue Falls | MT |
| Sales 2022 | 151M 165M | Sales 2023 | 148M 162M | Capitalization | 266M 291M |
|---|---|---|---|---|---|
| Net income 2022 | 11M 12.03M | Net income 2023 | 15M 16.41M | EV / Sales 2022 | 1.62 x |
| Net cash position 2022 | 39.31M 42.99M | Net cash position 2023 | 87.06M 95.22M | EV / Sales 2023 | 1.21 x |
| P/E ratio 2022 |
25.5
x | P/E ratio 2023 |
17.7
x | Employees | 273 |
| Yield 2022 |
2.09% | Yield 2023 |
2.86% | Free-Float | 25.99% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.70% | ||
| 1 week | +2.90% | ||
| Current month | +0.71% | ||
| 1 month | +4.41% | ||
| 3 months | +31.48% | ||
| 6 months | +35.24% | ||
| Current year | +26.79% |
1 week
135.00
144.00
1 month
130.00144.00
Current year
103.00144.00
1 year
103.00144.00
3 years
101.00175.00
5 years
101.00193.00
10 years
101.00219.50
| Managers | Title | Age | Since |
|---|---|---|---|
Claus Martini
CEO | Chief Executive Officer | 59 | 15-12-31 |
Hannes Leu
DFI | Director of Finance/CFO | 43 | 19-02-28 |
Bernd Deny
COO | Chief Operating Officer | 58 | 19-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Stefan Grote
BRD | Director/Board Member | 55 | 21-04-19 |
| Chairman | 52 | 22-04-25 | |
| Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 142 | -0.70% | 100 |
| 24-04-23 | 143 | 0.00% | 582 |
| 24-04-22 | 143 | +4.38% | 946 |
| 24-04-19 | 137 | 0.00% | 2,390 |
| 24-04-18 | 137 | -0.72% | 337 |
Delayed Quote Swiss Exchange, April 24, 2024 at 03:50 am EDT
More quotes
IVF HARTMANN Holding AG (IVF) is a Switzerland-based holding company engaged in the field of medical supplies. The Company's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Companyâs main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The Company also offers consulting services, on-site or in classrooms, related to the usage of its products. The Company's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. It also operates subsidiaries located in Switzerland.
| 1st Jan change | Capi. | |
|---|---|---|
| +26.79% | 374M | |
| -2.25% | 187B | |
| -1.32% | 108B | |
| -3.92% | 67.71B | |
| +7.99% | 53.07B | |
| +15.74% | 47.36B | |
| +6.01% | 39.73B | |
| +10.81% | 28.56B | |
| +2.34% | 26.55B | |
| +15.97% | 25.13B |
- Stock Market
- Equities
- VBSN Stock
